Loading ...McMaster University’s inhaled COVID-19 vaccine begins phase-2 human trials
The new vaccine is entirely Canadian, from design and biomanufacturing at McMaster’s Robert E. Fitzhenry Vector Laboratory to pre-clinical and clinical testing conducted by a team of Canadian experts, with Canadian participants, at Canadian research sites.
For the new trial, researchers hope to include 350 participants from across Canada at clinical trial sites in Hamilton, Ottawa, and Halifax. Those eligible for participation must:
- Have at least three doses of an mRNA COVID-19 vaccine
- Have never received the AstraZeneca COVID-19 vaccine
- Have not had a COVID-19 infection or COVID-19 vaccination within three months prior to enrollment
- Have no diagnosis of lung disease
- Be available to attend trial visits in-person
- Be age 18-65
EDIT ADDED
…be complete idiots